EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Advances in Omics, Computational Models, and Advanced Screening Methods for Drug Safety and Efficacy

Ahrum Son iD, Jongham Park, Woojin Kim, Yoonki Yoon, Sangwoon Lee, Jaeho Ji, Hyunsoo Kim iD

Toxics · 16.11.2024 · 12 (11) · 822

DOI: 10.3390/toxics12110822 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Toxics, online erschienen am 16.11.2024. Verfasst von Ahrum Son und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, Scripps Research, San Diego, CA 92037, USA. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF), Korea Basic Science Institute (National research Facilities and Equipment Center), Institute of Information & communications Technology Planning & Evaluation (IITP).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It is imperative to comprehend the mechanisms that underlie drug toxicity in order to enhance the efficacy and safety of novel therapeutic agents. The capacity to identify molecular pathways that contribute to drug-induced toxicity has been significantly enhanced by recent developments in omics technologies, such as transcriptomics, proteomics, and metabolomics. This has enabled the early identification of potential adverse effects. These insights are further enhanced by computational tools, including quantitative structure–activity relationship (QSAR) analyses and machine learning models, which accurately predict toxicity endpoints. Additionally, technologies such as physiologically based pharmacokinetic (PBPK) modeling and micro-physiological systems (MPS) provide more precise preclinical-to-clinical translation, thereby improving drug safety assessments. This review emphasizes the synergy between sophisticated screening technologies, in silico modeling, and omics data, emphasizing their roles in reducing late-stage drug development failures. Challenges persist in the integration of a variety of data types and the interpretation of intricate biological interactions, despite the progress that has been made. The development of standardized methodologies that further enhance predictive toxicology is contingent upon the ongoing collaboration between researchers, clinicians, and regulatory bodies. This collaboration ensures the development of therapeutic pharmaceuticals that are more effective and safer.

Schlagwörter

Stichwörter der Autor:innen

de novo drug designfragment-based drug designquantitative structure–activity relationshipstructure–activity relationshipvirtual screening

Autor:innen und Institutionen

  • Department of Molecular Medicine, Scripps Research, San Diego, CA 92037, USA.
  • Department of Bio-AI Convergence, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Republic of Korea.
  • Department of Convergent Bioscience and Informatics, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Republic of Korea.
  • Protein AI Design Institute, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Republic of Korea.
  • SCICS, Prove Beyond AI, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Republic of Korea.

ORCID-Profile: Ahrum Son, Hyunsoo Kim

Förderung

  • National Research Foundation of Korea (NRF)
  • Korea Basic Science Institute (National research Facilities and Equipment Center)
  • Institute of Information & communications Technology Planning & Evaluation (IITP)
  • Institute of Information and Communications Technology Planning and Evaluation (IITP) grant funded by the Korea government (MSIT)

Zitieren

APA

Son, A., Park, J., Kim, W., Yoon, Y., Lee, S., Ji, J., & Kim, H. (2024). Recent Advances in Omics, Computational Models, and Advanced Screening Methods for Drug Safety and Efficacy. Toxics, 12(11), 822. https://doi.org/10.3390/toxics12110822

Vancouver

Son A, Park J, Kim W, Yoon Y, Lee S, Ji J, et al. Recent Advances in Omics, Computational Models, and Advanced Screening Methods for Drug Safety and Efficacy. Toxics. 2024;12(11):822. doi:10.3390/toxics12110822

BibTeX
@article{Son2024,
  author = {Son, Ahrum and Park, Jongham and Kim, Woojin and Yoon, Yoonki and Lee, Sangwoon and Ji, Jaeho and Kim, Hyunsoo},
  title = {Recent Advances in Omics, Computational Models, and Advanced Screening Methods for Drug Safety and Efficacy},
  journal = {Toxics},
  year = {2024},
  volume = {12},
  number = {11},
  pages = {822},
  doi = {10.3390/toxics12110822}
}
Kostenlos starten →